Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 51–100 of 581 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06776406	Head Stabilization in Whole Brain RT	withdrawn	N/A	0	Abramson Cancer Center at Penn MedicineOTHER	1	Nov 25, 2025	clinicaltrials
NCT03274778	Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells	withdrawn	N/A	0	Oncology Institute of Southern SwitzerlandOTHER	1	Nov 18, 2025	clinicaltrials
NCT05954676